Drug intelligence / Profile preview

Zhizhike Granule

Development stage: Unknown
Lead developer: Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine
Administration: Oral

Overview

Zhizhike Granule is a Traditional Chinese Medicine (TCM) preparation developed by Guangxi University of Traditional Chinese Medicine and its affiliated Ruikang Hospital. It has been clinically used for over 20 years as a hospital preparation and is indicated for the treatment of acute tracheal bronchitis, particularly for conditions described as "wind-heat lung disease" in TCM. It is known for its effects in clearing lung and resolving phlegm, as well as its anti-inflammatory and antitussive properties.

Brand names: Zhizhike
Other names: 止得咳颗粒

Beyond the preview

Go deeper on Zhizhike Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhizhike Granule.

Explore the full profile